the HRPP Director will prepare a draft report within three (3) workdays after the IRB meeting at which the determination occurred.

Similar documents
Wayne State University Institutional Review Board

SUSPENSION OR TERMINATION OF HUMAN SUBJECTS RESEARCH

SOP 407: PROTOCOL DEVIATIONS AND UNANTICIPATED PROBLEMS

Institutional Review Board Standard Operating Procedure. Suspension and Termination of IRB Approval

Reporting an Unanticipated Problem Involving Risks to Subjects or Others (UPIRTSO) to the IRB

UNIVERSITY OF TENNESSEE GRADUATE SCHOOL OF MEDICINE INSTITUTIONAL REVIEW BOARD CONTINUING REVIEW AND REAPPROVAL OF RESEARCH

Administrative Hold, Suspension, or Termination of IRB Approval

Chapter 4 Institutional Review Board (IRB) Roles and Authorities

I. Summary. II. Responsibilities

Yale University Human Research Protection Program

Michigan State University Human Research Protection Program

University of Iowa External/Central IRB Reliance Process Standard Operating Procedure (SOP)

UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER INSTITUTIONAL REVIEW BOARD CONTINUING REVIEW OF RESEARCH

SOP 801: Investigator Qualifications and Responsibilities

CONTINUING REVIEW CRITERIA FOR RENEWAL

The Children s Hospital of Philadelphia Committee for the Protection of Human Subjects Policies and Procedures. Cooperative Agreements

Issue in IRB Approvals:

NONCOMPLIANCE. 1. Overview

CUNY HRPP Policy: Suspension or Termination of Human Subject Research

Research Involving Human Subjects: AA 110.7

Supersedes Document Dated: 7/7/11. SOP: RR 401 Version No.: 07 Version Date: 9/8/15 EXPEDITED REVIEW 1. POLICY

CONTINUING REVIEW CRITERIA FOR RENEWAL

SOP 903: HRPP AND NON-COMPLIANCE

SOP #2-2 Version #1 Date First Effective: December 14, Page 1 of 6

INSTITUTIONAL REVIEW BOARD (IRB) PROCEDURES

UNIVERSITY OF TENNESSEE GRADUATE SCHOOL OF MEDICINE INSTITUTIONAL REVIEW BOARD PROCEDURES FOR FULL BOARD REVIEW

SYRACUSE UNIVERSITY HUMAN RESEARCH PROTECTION PROGRAM STANDARD OPERATING PROCEDURES

Collaborative Research

Human Research Protection Program Policy

IOWA STATE UNIVERSITY Institutional Review Board. Policy on IRB Review of Protocol Deviations and Noncompliance for Non-exempt Research

IRB-REQUIRED INVESTIGATOR ACTIONS

AUTHORITY AND PURPOSE

COMPLIANCE MONITORING

Ceded IRB Review. The project involves prisoners or other vulnerable populations that require special considerations.

Effective Date: January 16, 2012 Policy Number: Appendix II. Revised Date: November 2, 2015 Oversight Level: Corporate

Florida State University IRB Standard Operational Procedures

OHRP Guidance on Written IRB Procedures

CONTINUING REVIEW 3/7/2016

CONTINUING REVIEW OF APPROVED IRB PROTOCOLS

Investigator Manual. If you have questions about whether an activity requires IRB review, contact the IRB Office.

November 30, Efficient Startup of Multi-site Research Studies: Central IRBs and National IRB Reliance Platforms

Institutional Responsibilities Under A Federalwide Assurance

University of Pennsylvania Institutional Review Board. Reliance Agreement Guidance: Post-Approval Submissions

IRB Chair Responsibilities

EXPEDITED REVIEW. Terms used in this policy, but not defined herein shall have the meanings set forth in the Glossary.

Centralized IRB Models

To assure knowledge and compliance by documenting the annual administrative review and continuing IRB review of non-exempt projects for the IRB.

Children s Hospital of Philadelphia Committees for the Protection of Human Subjects Policies and Procedures Continuing Review of Approved Research

University of Cincinnati. Radiation Safety Committee Operations Guidelines Statement of Policy (RSC Guidelines) RSC Guidelines (revision 5)

21 CFR Part 56 - Institutional Review Boards

EMERGENCY USE 03/02/2016

I. Summary. II. Responsibilities

Tuesday, May 15, Please be sure to sign in and take copies of each handout.

IRB MEETING ADMINISTRATION

7.0 DEVIATION and EXCEPTION of a PREVIOUSLY APPROVED PROTOCOL

SMART IRB Agreement Implementation Checklist and Documentation Tool

Illinois Institute of Technology Institutional Review Board Handbook of Procedures for the Protection of Human Research Subjects

To assure knowledge and compliance by documenting the continuing review procedure of approved projects for the IRB.

University of Wisconsin Colleges Administrative Policy #56 NON-COMPLIANCE IN HUMAN SUBJECTS RESEARCH

2.0 Institutional Review Board

CUNY HRPP Procedures: Multisite Non-Exempt Human Subjects Research

Procedure Department: HUMAN RESEARCH PROTECTIONS PROGRAM Policy Number: II.B.1

Initial Review. Approved By: Michele Kennett, JD, MSN, LLM Associate Vice Chancellor for Research. Table of Contents

THE UNIVERSITY OF SOUTH DAKOTA -- INSTITUTIONAL REVIEW BOARD -- STANDARD OPERATING PROCEDURES

Standard Operating Policy and Procedures (SOPP) 3:

Signature Date Date First Effective: Signature Date Revision Date: 05/14/2014

POLICY NO EXEMPT RESEARCH... 4 POLICY NO DISCLOSURE OF RESEARCH LAB TEST RESULTS... 5

Policies & Standard Operating Procedures

UNIVERSITY OF GEORGIA Institutional Review Board

Signature Date Date First Effective: Signature Date Revision Date: 07/18/2011

Date Effective 4/21/2008 Identification

Human Subjects in Research Review and Monitoring Form. Not applicable

Minot State University Institutional Review Board ANNUAL UPDATE/REVISION/PROJECT COMPLETION REPORT

INSTITUTIONAL REVIEW BOARD (IRB) PROCEDURES

Lapse in IRB Approval

Effective Date: January 16, 2012 Policy Number: MHC_RP0107. Revised Date: November 2, 2015 Oversight Level: Corporate

IRB Authorization Agreement Implementation Checklist and Documentation Tool

Your Roadmap to Single IRB Review Serving as a Reviewing IRB

IRB COMPOSITION AND IRB MEMBER ROLES AND RESPONSIBILITIES

What s New in GCP? FDA, OHRP Issue Harmonized Guidance on Transferring IRB Oversight of Clinical Studies

(y9. &i?r, JUL t Certified-Return Receipt Requested WARNING LE7TER

Cayuse IRB Policy and Procedure Manual

MISSISSIPPI STATE UNIVERSITY HUMAN RESEARCH PROTECTION PROGRAM. Collaborative Research and Performance Sites (01-23) Approved

Study Management SM STANDARD OPERATING PROCEDURE FOR Interactions with the Institutional Review Board (IRB)

Institutional Review Board (IRB) Policies and Procedures Manual

Office of the Vice President for Research

External IRB Instructions for the Registration Pathway in OSIRIS

Human Research Protections Program Medical College of Wisconsin and Froedtert Memorial Lutheran Hospital

Section 8. Continuing Review of Ongoing IRB-Approved Research (Revised 7/1/10)

DEPARTMENT OF HEALTH & HUMAN S E RVICES, 'mgr,':~~ MAY WARNING LETTE R

This policy defines the composition and requirements of the North Shore Medical Center (NSMC) Institutional Review Board (IRB) membership.

Guidance for IRBs, Clinical Investigators, and Sponsors IRB Continuing Review after Clinical Investigation Approval

Signature Date Date First Effective: Signature Date Revision Date:

Oklahoma State University Institutional Review Board Standard Operating Procedures

University of Pennsylvania Institutional Review Board. Reliance Agreement Guidance: Penn as Central IRB FAQ

I. Introduction. Institutional Authority Under Which the IRB is Established and Empowered (45 CFR )(21 CFR (a))

IV. Basic Procedures for Human Research Protections

Independent Ethics Committees

Current Status: Active PolicyStat ID: Origination: 04/2018 Effective: 04/2018 Approved: 04/2018 Last Revised: 04/2018 Expiration: 04/2021

The Top 10 Human Research Protection Compliance Risks

Transcription:

IRB Policy 34: Reporting Policy Revision Date: March 27, 2009, revised June 11, 2010, revised January 27, 2011, revised 9/23/13, revised 9/17/15, revised 4/2/18, revised 9/14/18 INSTITUTIONAL REVIEW BOARD REPORT OF FINDINGS I. Purpose / Background This policy establishes guidelines for the Office for the Protection of Human Research Subjects (OPHRS) to ensure prompt reporting in response to findings of a East Tennessee State University Institutional Review Board (IRB) or East Tennessee State University/VA IRB of those events listed in Federal regulations. These regulatory requirements may be found in 45 CFR 46.103(b)(5)(i) and 21 CFR 56.108(b)(1). II. Summary Policy A. Decisions by IRB Chair for VA studies only The VA IRB Vice-Chair will report via memorandum to the VA Facility Director (directly), the ACOS/R and the RCO within 5 business days of an IRB determination to suspend or terminate any VA research study. A copy of the memorandum will be kept on file with the R&D Service and IRB. B. Decisions by convened IRB If the IRB determines that an event represents: a. An unanticipated problem involving risks to subjects or others, b. A serious or continuing noncompliance with research regulations or determinations of the IRB, or c. A suspension or termination of IRB approval, the HRPP Director will prepare a draft report within three (3) workdays after the IRB meeting at which the determination occurred. For VA studies, when the IRB reviews either a local SAE or serious problem that are both unanticipated and related to the research, the IRB must notify the VA facility Director and the ACOS/R&D in writing within 5 business days after its convened meeting if: (a) Actions were taken to eliminate apparent immediate hazards to subjects; or

(b) The IRB determined that the incident was serious and unanticipated and related to the research, or there was insufficient information to make the determination; or (c) Protocol or informed consent modifications were warranted. For VA studies, when the IRB determines that serious or continuing noncompliance occurred, the IRB must notify the VA facility Director and the ACOS/R&D within 5 business days after making its determinations. For VA report of a local death that is both unanticipated and related, the IRB must notify the VA facility Director and the ACOS/R&D of its determinations within 5 business days of the determinations. For VA studies, when receiving a report of a suspension or termination of VA research, if the IRB determines that the suspension or termination meets either of these criteria; (a) Resulted from a local adverse event(s), local noncompliance, or other local issue(s); or (b) Requires local action (in addition to the suspension/termination) to ensure the safety, rights, or welfare of local human research subjects, personnel, or others or the effectiveness of the local HRPP; then (a) The IRB must notify the VA facility Director and the ACOS/R&D within 5 business days after the determination; (b) The VA facility Director must report the suspension/termination to ORO within 5 business days after receiving the IRB s notification. III. Report Contents The report will contain: a. A summary of the event, b. The findings of the organization, c. Actions taken by the organization or IRB, d. Reasons for the organization s or IRB s actions, and e. Plans for continued investigation or action, f. Project title, g. Principal Investigator, h. Federal Support, if any. IV. Report Distribution The HRPP Director in consultation with the IRB chair and the Vice Provost for Research (VPR) will finalize non-va reports within seven (7) working days after

the IRB meeting at which the final determination occurred. VA reports will be finalized within five working days after the IRB meeting at which the final determination occurred. For studies done under ETSU s assurance, the VPR will send the report to the following: a. The IRB (as a information item with the agenda), b. OHRP (whenever the research is subject to OHRP regulation) c. FDA (whenever the research is subject to FDA regulation), d. Department of Veterans Affairs AO* and VA Facility Director (whenever the research involves the use of shared facilities or VA employees or agents with appointments at both East Tennessee State University and the James H. Quillen Veterans Affairs Medical Center), e. Other Federal Agencies* that are a signatory to The Common Rule who conduct or oversee the research. f. Investigator. In addition, when the report involves unauthorized use, loss, or disclosure of individually identifiable patient information, the notification will be sent to the VA Privacy Officer. When the report involves violations of VA information security requirements, the report will be sent to the VHA Information Security Officer. (Refer to Policy 18 for immediate reporting requirements) For reports (serious or continuing non-compliance, suspensions or terminations, and UPIRTSOs) that are not subject to submission to FDA or OHRP, the VPR will provide a written response to the IRB s determinations. The response will include whether the VPR accepts the actions taken by the IRB, or requires additional actions on behalf of the institution. The HRPP Director will report to the following if the IRB or the VPR deems appropriate: a. Departmental chair, program director and supervisor of the investigator, b. Other organizations involved with the research, c. The sponsor, d. The funding agency, e. The Research and Sponsored Programs offices. For studies done under the assurance of Mountain States Health Alliance or the VA, that institution forwards the report to entities as noted above. A copy of the

correspondence must be provided to the Vice Provost for Research, ETSU, who ensures that reporting requirements have been met. *The VA AO forwards the report to the Research and Development Committee and the ACOS/Research. The VA facility Director must report to ORO within 5 business days after receiving notification of any situation that is reportable to ORO under Handbook 1058.01. The VA facility Director must ensure that ORO is notified by e-mail or telephone as soon as possible, but no longer than 2 business days, after becoming aware of: (a) Any research-related citation or determination of regulatory noncompliance issued by any State or Federal agency; or (b) Any situation covered by this Handbook that has generated media attention or Congressional interest. The VA Facility Director must report the following circumstances related to research information security incidents to ORO within 5 business days after taking or becoming aware of such action(s), regardless of the IRB determination: (1) Provision of an Issue Brief for VA Central Office regarding the incident; (2) Any notification to individual(s) of an information breach or provision of credit monitoring as required by the Network Security Operations Center (NSOC); (3) Any breach notification required under the Health Information Technology for Economic and Clinical Health (HITECH) Act; (4) Any notification to or from the Office of Inspector General (OIG) regarding the incident. Sources: Appendix A, Memo from Deputy Under Secretary for Health Operations and Management (DUSHOM) and Chief Research and Development Officer (CRADO) dated February 6, 2007

VHA Handbook 1058.01, 1 June 15, 2015